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Biodegradable hollow fibres of poly-L-lactic acid (PLEA) filled with a suspension of the contraceptive 
hormone levonorgestrel in castor oil were implanted subcutaneously in rats to study the rate of drug 
release, rate of biodegradation and tissue reaction caused by the implant. The in viva drug release was 
compared with the release in vitro using different release media. Fibres, disinfected with alcohol showed a 
zero-order release, both in vitro and in viva, for over 6 months. Fibres, either y-sterilized or disinfected with 
alcohol were harvested at time intervals ranging from 1 d to 6 months after implantation. Molecular 
weights of PLLA, tensile strengths, and remaining amounts of drug were determined as a function of 
time. 
The tissue reaction can be described as a very moderate foreign body reaction with the initial 
presence of macrophages, which are gradually replaced by fibroblasts which form a collagen capsule. 
Molecular weight determinations of PLEA showed a decrease from an initial M, of 1.59 X lo5 to 
5.5 X 19” in 4 months (after alcohol sterilization). A gradual decrease in fibre strength with time was 
observed which did not significantly impair the release rate of levonorgestrel. 
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The development of improved methods of drug delivery has 
received a lot of attention in the last two decades. In many 
cases a constant effective non-toxic level of the drug at a 
particular body location is needed. To reach this goal many 
variations of controlled release have been investigated. 
These include the useof bioerodible matrices’,’ (from which 
the drug is released by controlled degradation of the top 
layers of the matrix), microspheres or even nanoparticles, 
with a polymer body, (from which the drug is slowly 
released)3 or controlled delivery by (mini) devices4. 
The methods mentioned above may have one or more 
disadvantages e.g. (i) either no zero-order release can be 
achieved, (ii) the appliance cannot, or not easily, be removed 
in case of an emergency, (iii) an operation is needed to insert 
the device, (iv), the materials used are not optimally 
biocompatible. 
Therefore a release system was developed with none 
of these disadvantages 5-7 i.e. a hollow fibre of poly-L-lactic 
acid (PLLA) containing the drug suspended in oil from which 
it is released at a zero-order rate. Its dimensions (1 cm long, 
diam. 0.7 mm) allow a simple application, using a syringe. 
Correspondence to Dr J.M. Schakenraad. 
Removal of the fibre can easily be performed by a small 
incision, in case of an emergency. 
In this paper we present the results of studies on the 
in vivo and in vitro release of levonorgestrel from hollow 
fibres, the rate of biodegradation of the fibre material, and the 
cell-biological evaluation as a response to the subcutaneous 
implantation of the fibre in rats. 
MATERIALS AND METHODS 
Fibres. The hollow fibres were spun from poly-L-lactic acid 
(M, 159 000) using a ‘dry-wet’ coagulation spinning 
process5* 6 . The tube-in-orifice spinneret device contained an 
injection tube with an external diam. of 0.6 mm, an internal 
diam. of 0.4 mm, and an orifice diam. of 1 .O mm. The 
spinning dope was composed of 80% dioxane, 1 5% poly-L- 
lactic acid and 5% polyvinylpyrrolidine (PVP) at a temp. of 
50°C; water was used as the internal and external coagulant. 
The hollow fibres (Figure 7) obtained by this procedure 
(Batch no. 146-8) had an external diam. of 0.72 mm, an 
internal diam. of 0.47 mm and a wall thickness of 0.13 mm. 
The fibre consisted of a porous matrix with a dense non- 
porous skin (approx. 0.3 urn) on both sides. The fibres were 
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Figure 1 SEMs of (a) the fibre wall and (b) the outer surface 
cut at a length of 1.4 cm, filled with levonorgestrel suspended 
in castor oil (25% w/w) and heat-sealed at both ends. The 
effective length of the drug containing fibres was 1 .O cm. 
Experimentaldesign. Poly-L-lactic acid fibres were examined 
empty, filled with castor oil or filled with levonorgestrel 
suspended in castor oil. For each series we determined in vivo, 
as a function of time: tissue reaction, tensile strength of the 
fibre, molecular weight of the PLLA, residual levonorgestrel 
(if relevant). At day 1, day 2, day 4, 1 wk, 2 wk, 3 wk, 
1 month, 2 months, 4 months, 6 months and for tensile 
strength and molecular weight determinations also at 12 
months, 18 months and 24 months, fibres were harvested 
and examined for the previously mentioned parameters. For 
each parameter and time interval n = 6. 
contained only castor oil, six fibres were implanted in one rat. 
If fibres contained levonorgestrel, twofibres were implanted 
in one rat. 
Harvesting. At different harvesting times the rats were 
ether-anaesthetized and the fibres collected including the 
surrounding tissue. The fibres were immediately fixed in 2% 
glutaraldehyde in phosphate buffer (0.1 M, pH 7.4) for 
determination of tissue reaction, or processed for determina- 
tion of molecular weight, fibre strength or remaining fibre 
contents. 
Tissue reaction. The fibres with adhering tissue were 
transverselyvibratomized in 300 f.rm sections and postfixed 
with Karnovsky fixative. Dehydration was performed in an 
alcohol series followed by butyl-2,3_epoxypropylether. 
Subsequentlythespecimenswere embedded in Epon 10: 1. 
More contrast could be obtained after staining en bloc with 
2% (w/v) uranyl acetate in 10% (v/v) ethanol. Semi-thin 
sections (1 pm) were cut and appropriate areas were 
selected for making ultrathin sections (50 nm), which were 
subsequently evaluated in a transmission electron micro- 
scope (002A-Akashi) at 60 kV. The 1 pm sections were 
used for light microscopy after staining with toluidine blue 
and basic fuchsin. 
Tensile strength. Immediately after harvesting, the fibres 
were tested fortensile strength, using a tensile tester (Zwick 
1461). The initial length of the fibres was 0.5 cm. The rate of 
strain was 6 mm per min. The mean value of six determina- 
tions was calculated. 
Molecular weight. After harvesting, the fibrous capsule 
around the fibre was exposed to collagenase (50 IU/ml 
PBS) for 2 d. Subsequently the fibres were vacuum-dried 
and dissolved in dichloromethane. Determination of average 
molecularweight (M,) of PLLAwas performed by combined 
high performance gel permeation chromatography (g.p.c.) 
and low angle laser light scattering (1.a.l.l.s.) measurements. 
The g.p.c. unit, a h.p.1.c. equipped with 4 microstyragel 
columns (respectively 1 05, 1 04, IO3 and 500A). was 
connected with the 1.a.l.l.s. apparatus and a differential 
refractometer. 
Residual hormone determination of the fibres. Residual 
contents were dissolved in chloroform and the concentrations 
of the solutions were subsequently determined using a U.V. 
spectrophotometer (Unicam SP 800) at 247 nm. (The 
molecular extinction coefficient of levonorgestrel in chloro- 
form was 15 900 I mol-’ cm-‘. 
Sterilization. Fibres were either y-sterilized (2.5 Mrad) or 
disinfected with 70% alcohol, followed by drying in air. 
implantation procedure. The fibres were implanted sub- 
cutaneously in female AO/BN rats approx. 3 months old 
weighing 200-250 g.Aspeciallyadapted syringe (Figure2) 
was used for this purpose. The rat was shaved on its back 
which was subsequently disinfected with alcohol, before the 
fibres were implanted. Six fibres were implanted per 
parameter and time interval. If fibres were empty or 
In vitrorelease studies. Hollow fibres were filled with a 25% 
(w/w) dispersion of micronized 3H-labelled levonorgestrel 
(obtained from Schering, FRG), in castor oil and placed in 
either 45/55% (v/v) ethanol/water or 30/70% ethanol/ 
water mixtures, which were then continuously shaken at 
37°C. Every fourth day a 200 ~1 sample was taken and 
placed in 4 ml Lipoluma counting liquid (Hicol) and counted 
by liquid scintillation, using a LKB-Wallac 12 19 counter. 
Figure 2 Syringe used for injecting hollow fibres. 
RESULTS 
ln vitro release studies using tritiated levonorgestrel (30,’ 
70% ethanol/water mixture) showed a near zero-order 
release rate over a period of more than 320 d, resulting in a 
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release rate of approx. 2 pg/d (Figure 3). After day 140 a 
slight increase in the release rate was observed, possibly due 
to degradation of the fibre material. 
In vivo release studies using fibres, disinfected with 
alcohol, showed a release rate of approx. 2.4 pg/d result- 
ing in a release period of over 180 d (Figure 4). After 
y-sterilization of levonorgestrel containingfibres nozero-order 
release rate could be demonstrated. Apparently the 
y-sterilization affects the structure of the fibre wall (by 
diminishing M, of PLLA to l/3) and also causes chemical 
modification of the levonorgestrel (Figure 7 1). Biodegrada- 
tion of the fibre was followed by measuring the tensile 
strength (Figure 5) and molecular weight as a function of 
time (Figure 6). Tensile strength measurements performed 
at different implantation times showed a behaviour corres- 
ponding with the changes in wW. The fibrous capsule that is 
formed around the hollow fibre increases the tensile 
strength by approximately 30 g (as measured in a separate 
determination). After y-sterilization the i&w immediately 
dropped from 159 000 to 65 000: 6 months after implanta- 
tion the gi, had further decreased to 39 000. After alcohol 
sterilization, a decrease in M, to 55 000 was observed after 
120 d of implantation. 
Cell-biological evaluation of the ‘healing process’ 
demonstrated that the fibre surface was initially covered 
with granulocytes and macrophages. After 2 d, the granu- 
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Figure 5 Tensile strength of alcohol (ethanol) (A) and y- (G) sterilized fibres 
as a function of time. F, tensile strength in grams. 
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Figure 3 In vitro release of 3H-levonorgestrel from poly-L-tactic acid fibres 
in ethaffol/weter /30/70%~ 
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Figure 4 In vivo release of ie~ono#estrei from poly-L-lactic acid fibres 
implanted in rats, after ethanol (A) and afrer y- (G] sterilization. 
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Figure 6 ~a~ecolar weight of afcohol (etha~o/~ (Aj end y- /G) sterilized 
fibres as a function of time. 
locytes disappeared and capillaries were activated to bud. At 
day 7, macrophages formed a complete monolayer around 
the fibre. The cell membrane contacting the fibre, closely 
followed the smooth contours of the polymer, at a regular 
distance of approx. IO nm (Figure 7). 
The local formation of close contacts and focal 
adhesions could be observed. The cells were metabolically 
very active as judged by the amount of mitochondria, both 
smooth and rough endoplasmatic reticulum and Golgi 
apparatus (Figure 8). The macrophages at the cell-polymer 
interphase showed a remarkable appearance. At their cell 
membrane not facing the polymer, microvillous structures 
were observed, sometimes interdigitating with neighbouring 
cells (Figure 9). 
From 2 wk on, a layer of fibroblasts was observed 
surrounding the macrophages. These fibroblasts started to 
produce a collagen sheet around the fibre, and gradually the 
macrophages disappeared (Figure 70). At 6 months a 
mature fibrous capsule was formed around the fibre, with 
both circularly and longitudinally arranged fibres. At places 
where more mechanical stress occurred, (at the lateral edges 
of fibres) a thicker layer could be observed. No chronic 
infection, foreign body reaction or the formation of giant cells 
was observed. 
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100 nm 
Figure 7 Macrophage at a regular distance of approx. 10 nm from the 
poly-L-lactide fibre wall. 
Figure 8 Active cell-polymer interface. 
DISCUSSION 
The results demonstrate that with our new release system 
both in vivo and in vitro a near zero-order release of 
levonorgestrel from PLLA fibres is obtained. The initial 
purpose which was to obtain zero-order release for 6 months 
is met easily. 
Biodegradation of the fibre material, as monitored by 
tensile strength and M, determinations, starts immediately 
after implantation. The fibres, however, retained their shape 
and function until the total contents had been released. 
Complete degradation or fragmentation of the fibres 
was not observed during the time they were studied, 
although it was observed that from 4 wk onwards some of 
the fibres showed defects. The fibre parts however were 
surrounded by a fibrous capsule and remained in their 
original positions. It might be expected that breaking of the 
fibre would result in a significant increase in drug release 
rates. Only a minor increase was observed however and it 
was concluded that in case of defects in the fibre wall only a 
small area of the total surface develops where the suspension 
in oil is directly exposed to the fibrous capsule. This did not 
contribute greatly to the total release rate. 
Figure 9 Microvillous structure at the side of the cell not facing the 
polymer. 
Figure 10 Collagen formation around the fibre (a) and (b) 
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Figure 11 U.V. spectrum of levonorgestrel before ( -) and after (---) 
y-sterilization with 2.5 Mrad. 
In vitro, a perfect zero-order release rate was observed. 
These determinations were performed in 30/70% ethanol/ 
water mixtures and it could be expected that the in vivo 
release was somewhat lower since levonorgestrel dissolves 
better in alcohol than in water. It could also be expected that 
the encapsulation of the fibre might impair the zero-order 
rate release. However, we observed a slightly higher release 
in vivo, which could still be described as near zero-order, at 
least when the fibres were alcohol disinfected. Apparently 
encapsulation does not inhibit the amount of drug release 
significantly and does not influence the rate of release. 
The cellular response to the poly-L-lactic acid fibre 
could be described as a very moderate foreign body reaction, 
which is composed of two components, a primary wound 
healing process and an attempt by the macrophages to 
engulf the foreign body. Initially a large number of neutro- 
philic granulocytes and a smaller number of eosinophilic 
granulocytes migrate towards the fibres, followed by the 
macrophages. This response is presumably evoked by the 
tissue damage induced by the implantation itself. It can be 
described as a primary wound healing process. After 3 d the 
granulocytes gradually disappear and macrophages cover 
the graft interface. These macrophages seem quite meta- 
bolically active but no degradation of the fibre could be 
observed as a result of their actions. Possibly, the macro- 
phages try to engulf the foreign body, but fail to do so8. The 
absence of foreign body giant cells and lymphoid elements 
indicates that the graft can be regarded as quite inert; 
eventually the macrophage phagocytic activity was low and 
the graft did not induce a chronic inflammationE-‘O. 
The appearance of fingerlike extensions of macro- 
phages after 1 wk of implantation on the side of the cell not 
facing the fibre has also been described by others”. 
Salthouse’ suggested that these structures (called lamellop- 
odia) were involved in engulfing polymer debris and were 
indicative of macrophage activity. However, in our model, the 
polymer to be engulfed is situated at the opposite side of the 
cell. We therefore consider it a foreign body induced surface 
enlargement. Since membrane processes in cellular metabolic 
activity can only take place at the side of the cell not facing 
the polymer this metabolic effective membrane surface may 
enlarge, in the way described, as a compensation mechanism. 
In vitro release studies have been performed in 
45/559/o and 30/70% ethanol/water mixtures. Release 
rates were highest when more ethanol was present in the 
medium. The release rate in the 45/55% medium was 
approx. 12 pg cm-’ (24 h)-‘. The release rate in the 30/70% 
medium was approx. 2 j.rg cm-’ (24 h)-’ (see Figure 3). The 
release rate in vivo however was somewhat higher (approx. 
2.4 j.rg cm-’ (24 h))’ which is not in accordance with 
expectations. 
y-Irradiation of the fibres filled with levonorgestrel 
caused not only a decrease in the M, of the poly-L-lactic acid 
from 159 000 to 65 000 but the levonorgestrel was also 
damaged, as judged by the change in the U.V. spectrum 
(Figure 17). The occurrence of a shoulder at lower wave- 
numbers indicates the presence of low molecular degradation 
products of levonorgestrel. Moreover, after y-sterilization, 
thein vivo release rate was not of zero-order. When the fibre 
is filled with the drug after it has been sterilized, the problem 
does not occur. 
Alternative applications for the hollow fibres are now 
being considered, such as cytostatics, antibiotics or hormones 
(e.g. LH-RH). The fibre wall has to be adapted for these 
purposes. 
CONCLUSION 
The biodegradable hollow fibre of poly-L-lactic acid evokes 
only a very moderate foreign body reaction and is therefore a 
suitable device for the release of drugs over a long period of 
time. 
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